It has become evident that expression of many KLKs is regulated by steroid hormones in a tissue-specific manner, such as KLK2, PSA/KLK3 and KLK4 by androgen in prostate and breast cancer cells, and KLK4 by estrogen in endometrial and ovarian cancer cells [49–52]. Here, KLK3 is linked to ovarian carcinoma.